SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001395064-20-000081
Filing Date
2020-06-03
Accepted
2020-06-03 06:07:25
Documents
1
Period of Report
2019-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_159117882285800.html 3  
1 FORM 3 wf-form3_159117882285800.xml 3 3097
  Complete submission text file 0001395064-20-000081.txt   4780
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38550 | Film No.: 20938874
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Issuer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)